DataLend: Securities Lending Revenue Down 16% Year-Over-Year to $2.53 Billion in Q2 2024

Global revenue declines year-over-year due to lagging equities performance in the U.S. and EMEA NEW YORK, July 2, 2024 /PRNewswire/ -- The global securities finance industry generated $2.53 billion i

PR Newswire12:30 ET

China's Bilibili And Ollie's Bargain Outlet Were Among 10 Mid Cap Stocks With Biggest Gains In The Last Week (June 16-June 22, 2024): Are They In Your Portfolio?

These mid-cap stocks were the best performers in the last week. Are they in your portfolio?Bilibili Inc. (NASDAQ:BILI) shares rose 23.32% following last week's release of 'San Guo: Mou Ding Tian Xia.'

BenzingaJun 23 18:21 ET

ImmunityBio Shares Are Trading Higher on Continued Strength After the Company on Thursday Announced Insurance Coverage of ANKTIVA Across Multiple States With First Commercial Doses Administered.

ImmunityBio Shares Are Trading Higher on Continued Strength After the Company on Thursday Announced Insurance Coverage of ANKTIVA Across Multiple States With First Commercial Doses Administered.

BenzingaJun 21 11:40 ET

Sector Update: Health Care Stocks Mixed Thursday Afternoon

Health care stocks were mixed Thursday afternoon, with the NYSE Health Care Index down 0.2% and the Health Care Select Sector SPDR Fund (XLV) up 0.1%. The iShares Biotechnology ETF (IBB) rose 0.9%. In

MT NewswiresJun 20 13:59 ET

Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Jabil Inc. (NYSE:JBL) fell sharply during Thursday's session following third-quarter results.Jabil reported third-quarter fiscal 2024 revenue of $6.77 billion, down by 20.2% year-on-year, be

BenzingaJun 20 13:26 ET

Why ImmunityBio Stock Is Trading Higher Thursday

ImmunityBio, Inc. (NASDAQ:IBRX) shares are moving higher Thursday after the company announced insurance coverage of ANKTIVA across multiple states.The Details: ANKTIVA is a immunotherapy used to treat

BenzingaJun 20 12:49 ET